EP1165828A4 - 50 human secreted proteins - Google Patents

50 human secreted proteins

Info

Publication number: EP1165828A4
Authority: EP; European Patent Office
Prior art keywords: secreted proteins; human secreted; human; proteins; secreted
Prior art date: 1999-03-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00919570A

Other languages

German (de)

French (fr)

Other versions

EP1165828A1 (en

Inventor

Craig A Rosen

Steven M Ruben

George Komatsoulis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-26

Filing date

2000-03-23

Publication date

2002-09-25

2000-03-23 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2002-01-02 Publication of EP1165828A1 publication Critical patent/EP1165828A1/en

2002-09-25 Publication of EP1165828A4 publication Critical patent/EP1165828A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EP00919570A 1999-03-26 2000-03-23 50 human secreted proteins Withdrawn EP1165828A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US12650899P	1999-03-26	1999-03-26
US126508P		1999-03-26
US17487100P	2000-01-07	2000-01-07
US174871P		2000-01-07
PCT/US2000/007722 WO2000058496A1 (en)	1999-03-26	2000-03-23	50 human secreted proteins

Publications (2)

Publication Number	Publication Date
EP1165828A1 EP1165828A1 (en)	2002-01-02
EP1165828A4 true EP1165828A4 (en)	2002-09-25

Family

ID=26824743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00919570A Withdrawn EP1165828A4 (en)	1999-03-26	2000-03-23	50 human secreted proteins

Country Status (5)

Country	Link
EP (1)	EP1165828A4 (en)
JP (1)	JP2002539843A (en)
AU (1)	AU4023200A (en)
CA (1)	CA2370441A1 (en)
WO (1)	WO2000058496A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6770461B1 (en)	1998-10-23	2004-08-03	Genome Therapeutics Corporation	High bone mass gene of 11q13.3
US6511834B1 (en)	2000-03-24	2003-01-28	Millennium Pharmaceuticals, Inc.	32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
US6627423B2 (en)	2000-03-24	2003-09-30	Millennium Pharmaceuticals, Inc.	21481, a novel dehydrogenase molecule and uses therefor
EP1268775B1 (en) *	2000-04-05	2008-11-19	Oscient Pharmaceuticals Corporation	The high bone mass gene of 11q13.3
US7514594B2 (en)	2001-05-11	2009-04-07	Wyeth	Transgenic animal model of bone mass modulation
WO2002092000A2 (en)	2001-05-11	2002-11-21	Genome Therapeutics Corporation	Hbm variants that modulate bone mass and lipid levels

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5792628A (en) *	1997-03-14	1998-08-11	Bowman; Michael	Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (en) *	1997-04-16	1998-10-22	Millennium Biotherapeutics	Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
EP0879887A1 (en) *	1997-05-21	1998-11-25	Smithkline Beecham Corporation	A human gene similar to a secreted murine protein SDF5 (ATG-1622)
WO2000027994A2 (en) *	1998-11-12	2000-05-18	The Regents Of The University Of California	Chlamydia pneumoniae genome sequence
WO2000058350A1 (en) *	1999-03-26	2000-10-05	Human Genome Sciences, Inc.	49 human secreted proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5688927A (en) *	1995-06-07	1997-11-18	Icos Corporation	Macrophage derived chemokine

2000
- 2000-03-23 CA CA002370441A patent/CA2370441A1/en not_active Abandoned
- 2000-03-23 WO PCT/US2000/007722 patent/WO2000058496A1/en not_active Application Discontinuation
- 2000-03-23 AU AU40232/00A patent/AU4023200A/en not_active Abandoned
- 2000-03-23 JP JP2000608775A patent/JP2002539843A/en not_active Withdrawn
- 2000-03-23 EP EP00919570A patent/EP1165828A4/en not_active Withdrawn

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5792628A (en) *	1997-03-14	1998-08-11	Bowman; Michael	Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (en) *	1997-04-16	1998-10-22	Millennium Biotherapeutics	Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
EP0879887A1 (en) *	1997-05-21	1998-11-25	Smithkline Beecham Corporation	A human gene similar to a secreted murine protein SDF5 (ATG-1622)
WO2000027994A2 (en) *	1998-11-12	2000-05-18	The Regents Of The University Of California	Chlamydia pneumoniae genome sequence
WO2000058350A1 (en) *	1999-03-26	2000-10-05	Human Genome Sciences, Inc.	49 human secreted proteins

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 24 August 1998 (1998-08-24), XP002195266 *
DATABASE EMBL 25 July 1996 (1996-07-25), XP002195263 *
DATABASE EMBL 25 July 1996 (1996-07-25), XP002195264 *
DATABASE EMBL 27 October 1994 (1994-10-27), XP002195267 *
DATABASE EMBL 6 August 1999 (1999-08-06), XP002195262 *
DATABASE EMBL 8 January 1998 (1998-01-08), XP002195265 *
DATABASE SWISSPROT 1 November 1997 (1997-11-01), XP002195268 *
See also references of WO0058496A1 *

Also Published As

Publication number	Publication date
JP2002539843A (en)	2002-11-26
EP1165828A1 (en)	2002-01-02
WO2000058496A1 (en)	2000-10-05
CA2370441A1 (en)	2000-10-05
AU4023200A (en)	2000-10-16

Publication	Publication Date	Title
EP1218408A4 (en)	2003-02-26	32 human secreted proteins
EP1212343A4 (en)	2004-11-03	52 human secreted proteins
EP1181390A4 (en)	2004-08-04	27 human secreted proteins
EP1224285A4 (en)	2004-12-08	27 human secreted proteins
EP1212342A4 (en)	2003-04-02	18 human secreted proteins
EP1226231A4 (en)	2003-07-09	19 human secreted proteins
EP1175438A4 (en)	2002-10-30	62 human secreted proteins
EP1192176A4 (en)	2003-03-05	49 human secreted proteins
EP1192278A4 (en)	2003-05-28	48 human secreted proteins
EP1175439A4 (en)	2002-10-09	49 human secreted proteins
EP1165827A4 (en)	2003-05-02	45 human secreted proteins
EP1159284A4 (en)	2003-10-29	33 human secreted proteins
EP1189917A4 (en)	2003-11-05	48 human secreted proteins
EP1185543A4 (en)	2003-09-03	50 human secreted proteins
EP1224201A4 (en)	2005-03-02	32 human secreted proteins
EP1203005A4 (en)	2004-11-24	25 human secreted proteins
EP1173477A4 (en)	2003-02-26	49 human secreted proteins
EP1206573A4 (en)	2004-08-04	26 human secreted proteins
EP1144614A4 (en)	2003-08-06	33 human secreted proteins
EP1169332A4 (en)	2003-09-03	49 human secreted proteins
EP1165602A4 (en)	2002-10-09	49 human secreted proteins
EP1171460A4 (en)	2002-10-09	48 human secreted proteins
EP1165828A4 (en)	2002-09-25	50 human secreted proteins
EP1185285A4 (en)	2003-02-19	49 human secreted proteins
EP1228082A4 (en)	2005-11-16	29 human secreted proteins

Legal Events

Date	Code	Title	Description
2001-11-16	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-01-02	17P	Request for examination filed	Effective date: 20010926
2002-01-02	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-01-02	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2002-06-05	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 39/00 A, 7G 01N 33/53 B
2002-09-25	A4	Supplementary search report drawn up and despatched	Effective date: 20020808
2002-09-25	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2003-08-27	17Q	First examination report despatched	Effective date: 20030715
2004-11-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-12-29	18D	Application deemed to be withdrawn	Effective date: 20040615